Agilent Applied sciences A is getting ready to launch its quarterly earnings on Monday, 2024-11-25. Here is a short overview of what buyers ought to take into account earlier than the announcement.
Analysts anticipate Agilent Applied sciences to report an earnings per share (EPS) of $1.40.
Traders in Agilent Applied sciences are eagerly awaiting the corporate’s announcement, hoping for information of surpassing estimates and constructive steering for the following quarter.
It is price noting for brand new buyers that inventory costs will be closely influenced by future projections somewhat than simply previous efficiency.
Earnings Observe Document
Final quarter the corporate beat EPS by $0.06, which was adopted by a 0.16% improve within the share worth the following day.
Here is a have a look at Agilent Applied sciences’s previous efficiency and the ensuing worth change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | This fall 2023 |
---|---|---|---|---|
EPS Estimate | 1.26 | 1.19 | 1.22 | 1.35 |
EPS Precise | 1.32 | 1.22 | 1.29 | 1.38 |
Worth Change % | 0.0% | -10.0% | 3.0% | 9.0% |
Market Efficiency of Agilent Applied sciences’s Inventory
Shares of Agilent Applied sciences had been buying and selling at $132.06 as of November 21. During the last 52-week interval, shares are up 5.86%. On condition that these returns are typically constructive, long-term shareholders ought to be happy going into this earnings launch.
Analyst Observations about Agilent Applied sciences
Understanding market sentiments and expectations throughout the business is essential for buyers. This evaluation delves into the newest insights on Agilent Applied sciences.
Analysts have offered Agilent Applied sciences with 3 scores, leading to a consensus score of Impartial. The common one-year worth goal stands at $149.0, suggesting a possible 12.83% upside.
Evaluating Rankings Amongst Trade Friends
On this evaluation, we delve into the analyst scores and common 1-year worth targets of IQVIA Hldgs, Waters and Illumina, three key business gamers, providing insights into their relative efficiency expectations and market positioning.
- The prevailing sentiment amongst analysts is an Outperform trajectory for IQVIA Hldgs, with a mean 1-year worth goal of $261.21, implying a possible 97.8% upside.
- The prevailing sentiment amongst analysts is an Impartial trajectory for Waters, with a mean 1-year worth goal of $370.0, implying a possible 180.18% upside.
- For Illumina, analysts mission an Impartial trajectory, with a mean 1-year worth goal of $173.56, indicating a possible 31.43% upside.
Abstract of Friends Evaluation
The peer evaluation abstract offers a snapshot of key metrics for IQVIA Hldgs, Waters and Illumina, illuminating their respective standings throughout the business. These metrics provide beneficial insights into their market positions and comparative efficiency.
Firm | Consensus | Income Progress | Gross Revenue | Return on Fairness |
---|---|---|---|---|
Agilent Applied sciences | Impartial | -5.62% | $855M | 4.65% |
IQVIA Hldgs | Outperform | 4.28% | $1.38B | 4.17% |
Waters | Impartial | 4.02% | $438.65M | 10.71% |
Illumina | Impartial | -3.49% | $745M | 39.60% |
Key Takeaway:
Agilent Applied sciences ranks within the center amongst friends for Consensus score. It’s on the backside for Income Progress. For Gross Revenue, it’s on the high. By way of Return on Fairness, Agilent Applied sciences is on the backside in comparison with its friends.
Delving into Agilent Applied sciences’s Background
Initially spun out of Hewlett-Packard in 1999, Agilent has advanced into a number one life science and diagnostic agency. At this time, Agilent’s measurement applied sciences serve a broad base of shoppers with its three working segments: life science and utilized instruments, cross lab consisting of consumables and providers associated to life science and utilized instruments, and diagnostics and genomics. Over half of its gross sales are generated from the biopharmaceutical, chemical, and superior supplies finish markets, which we view because the stickiest finish markets, but it surely additionally helps scientific lab, environmental, forensics, meals, tutorial, and government-related organizations. The corporate is geographically numerous, with operations within the US and China representing the biggest nation concentrations.
Agilent Applied sciences: A Monetary Overview
Market Capitalization: Positioned above business common, the corporate’s market capitalization underscores its superiority in measurement, indicative of a robust market presence.
Income Progress: Agilent Applied sciences’s income progress over a interval of three months has confronted challenges. As of 31 July, 2024, the corporate skilled a income decline of roughly -5.62%. This means a lower within the firm’s top-line earnings. As in comparison with opponents, the corporate encountered difficulties, with a progress price decrease than the common amongst friends within the Well being Care sector.
Web Margin: Agilent Applied sciences’s web margin excels past business benchmarks, reaching 17.87%. This signifies environment friendly price administration and robust monetary well being.
Return on Fairness (ROE): Agilent Applied sciences’s ROE stands out, surpassing business averages. With a formidable ROE of 4.65%, the corporate demonstrates efficient use of fairness capital and robust monetary efficiency.
Return on Property (ROA): Agilent Applied sciences’s monetary power is mirrored in its distinctive ROA, which exceeds business averages. With a outstanding ROA of 2.58%, the corporate showcases environment friendly use of property and robust monetary well being.
Debt Administration: With a below-average debt-to-equity ratio of 0.5, Agilent Applied sciences adopts a prudent monetary technique, indicating a balanced method to debt administration.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.